Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The average weight loss on retatrutide in clinical trials has been up to 24% of body weight, which is significantly higher than other GLP-1 receptor agonists like semaglutide
The trade-off: retatrutide produces substantially higher weight loss with a higher discontinuation rate
Your clinician will review your progress regularly and adjust your treatment if needed, helping you find the dose that works best for you
IV Therapy is often considered elective and may not be covered by insurance
2021;11:e048391
(PubMed) Rolim LC, da Silva EM, Flumignan RL, Abreu MM, Dib SA
US$ 21.07
US$ 24.70
US$ 24.50
US$ 29.94
US$ 24.76
US$ 25.69
